Search

Contains fulltext : 287842.pdf (Publisher’s version ) (Open Access) Background Women with PTEN Hamartoma Tumor Syndrome (PHTS) are offered breast cancer (BC) surveillance because of an increased BC lifetime risk. Surveillance guidelines are, however, expert opinion?based because of a lack of data. We aimed to assess the yield and effectiveness of BC surveillance and the prevalence and type of breast disease in women with PHTS. Methods Sixty-five women with PHTS who visited our center between 2001 and 2021 were included. Surveillance consisted of annual magnetic resonance imaging (MRI) and mammography from ages 25 and 30?years, respectively. Results Thirty-nine women enrolled in the BC surveillance program (median age at first examination, 38?years [range, 24?70]) and underwent 156 surveillance rounds. Surveillance led to detection of BC in 7/39 women (cancer detection rate [CDR], 45/1000 rounds) and benign breast lesions (BBLs) in 11/39 women. Overall sensitivity2 (which excludes prophylactic-mastectomy detected BCs) was 100%, whereas sensitivity2 of mammography and MRI alone was 50% and 100%, respectively. Overall specificity was higher in follow-up rounds (86%) versus first rounds (71%). Regardless of surveillance, 21/65 women developed 35 distinct BCs (median age at first diagnosis, 40?years [range, 24?59]) and 23/65 developed 89 BBLs (median age at first diagnosis, 38?years [range, 15?61]). Surveillance-detected BCs were all T1 and N0, whereas outside surveillance-detected BCs were more often ≥T2 (60%) and N+ (45%) (p?.005). Conclusions The findings show that annual BC surveillance with MRI starting at age 25?years enables detection of early-stage BCs. Performance measures of surveillance and CDR were both high. BBLs were commonly present, underlining the importance of evaluation of all lesions independently. Lay summary Breast cancer surveillance leads to decreased tumor stage and improved survival. Breast cancer surveillance with breast magnetic resonance imaging from age 25?years onward is recommended.

Purpose: Automated 3D breast ultrasound (ABUS) has been proposed as a complementary screening modality to mammography for early detection of breast cancers. To facilitate the interpretation of ABUS images, automated diagnosis and detection techniques are being developed, in which malignant lesion segmentation plays an important role. However, automated segmentation of cancer in ABUS is challenging since lesion edges might not be well defined. In this study, the authors aim at developing an automated segmentation method for malignant lesions in ABUS that is robust to ill-defined cancer edges and posterior shadowing. Methods: A segmentation method using depth-guided dynamic programming based on spiral scanning is proposed. The method automatically adjusts aggressiveness of the segmentation according to the position of the voxels relative to the lesion center. Segmentation is more aggressive in the upper part of the lesion (close to the transducer) than at the bottom (far away from the transducer), where posterior shadowing is usually visible. The authors used Dice similarity coefficient (Dice) for evaluation. The proposed method is compared to existing state of the art approaches such as graph cut, level set, and smart opening and an existing dynamic programming method without depth dependence. Results: In a dataset of 78 cancers, our proposed segmentation method achieved a mean Dice of 0.73 ± 0.14. The method outperforms an existing dynamic programming method (0.70 ± 0.16) on this task (p = 0.03) and it is also significantly (p < 0.001) better than graph cut (0.66 ± 0.18), level set based approach (0.63 ± 0.20) and smart opening (0.65 ± 0.12). Conclusions: The proposed depth-guided dynamic programming method achieves accurate breast malignant lesion segmentation results in automated breast ultrasound.

Purpose: With novel MRIsequences, high spatiotemporal resolution has become available in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the breast. Since benign structures in the breast can show enhancement similar to malignancies in DCE-MRI, characterization of detected lesions is an important problem. The purpose of this study is to develop a computer-aided diagnosis(CADx)system for characterization of breast lesions imaged with high spatiotemporal resolution DCE-MRI. Methods: The developed CADxsystem is composed of four main parts: semiautomated lesion segmentation, automated computation of morphological and dynamic features, aorta detection, and classification between benign and malignant categories. Lesion segmentation is performed by using a “multiseed smart opening” algorithm. Five morphological features were computed based on the segmentation of the lesion. For each voxel, contrast enhancement curve was fitted to an exponential model and dynamic features were computed based on this fitted curve. Average and standard deviations of the dynamic features were computed over the entire segmented area, in addition to the average value in an automatically selected smaller “most suspicious region.” To compute the dynamic features for an enhancement curve, information of aortic enhancement is also needed. To keep the system fully automated, the authors developed a component which automatically detects the aorta and computes the aortic enhancement time. The authors used random forests algorithm to classify benign lesions from malignant. The authors evaluated this system in a dataset of breast MRI scans of 325 patients with 223 malignant and 172 benign lesions and compared its performance to an existing approach. The authors also evaluated the classification performances for ductal carcinomain situ (DCIS), invasive ductal carcinoma (IDC), and invasive lobular carcinoma (ILC) lesions separately. The classification performances were measured by receiver operating characteristic (ROC) analysis in a leave-one-out cross validation scheme. Results: The area under the ROC curve (AUC) obtained by the proposed CADxsystem was 0.8543, which was significantly higher (p = 0.007) than the performance obtained by the previous CADxsystem (0.8172) on the same dataset. The AUC values for DCIS, IDC, and ILC lesions were 0.7924, 0.8688, and 0.8650, respectively. Conclusions: The authors developed a CADxsystem for high spatiotemporal resolution DCE-MRI of the breast. This system outperforms a previously proposed system in classifying benign and malignant lesions, while it requires less user interactions.

Purpose: Automated 3D breast ultrasound (ABUS) has gained interest in breast imaging. Especially for screening women with dense breasts, ABUS appears to be beneficial. However, since the amount of data generated is large, the risk of oversight errors is substantial. Computer aided detection (CADe) may be used as a second reader to prevent oversight errors. When CADe is used in this fashion, it is essential that small cancers are detected, while the number of false positive findings should remain acceptable. In this work, the authors improve their previously developed CADe system in the initial candidate detection stage. Methods: The authors use a large number of 2D Haar-like features to differentiate lesion structures from false positives. Using a cascade of GentleBoost classifiers that combines these features, a likelihood score, highly specific for small cancers, can be efficiently computed. The likelihood scores are added to the previously developed voxel features to improve detection. Results: The method was tested in a dataset of 414 ABUS volumes with 211 cancers. Cancers had a mean size of 14.72 mm. Free-response receiver operating characteristic analysis was performed to evaluate the performance of the algorithm with and without using the aforementioned Haar-like feature likelihood scores. After the initial detection stage, the number of missed cancer was reduced by 18.8% after adding Haar-like feature likelihood scores. Conclusions: The proposed technique significantly improves our previously developed CADe system in the initial candidate detection stage.